A panel of autism scientists and advocates is charged with a tall order: making recommendations for the care of autistic people worldwide.
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
Researchers say they are unimpressed with a study that underpins a tech company’s new digital therapy for autism.
Two drugs that alter the activity of the hormone vasopressin seem to improve social communication in autistic people, but some experts question the findings.
Researchers are edging closer to a therapy for Angelman syndrome — a condition related to autism — that involves injecting the gene-editing enzyme CRISPR into the fetal brain.
The popularity of mobile devices offers families the promise of communication with their autistic child, but success is more than a click away.
Parents of autistic children are paying tens of thousands of dollars for stem cell therapies that often use medical waste. Despite the risks, regulators have been slow to act.
A much-touted behavioral therapy for autism, the Early Start Denver Model, may not be as effective as its creators had hoped.
An experimental compound that blocks two enzymes involved in gene expression improves social behavior in young mice.